HALO logo
halo search icon
Gilead Sciences, Inc.

US$130.69

Price Change Indicator
0.19 (0.146%)
Gilead Sciences, Inc.
GILD · NAS

Gilead Sciences, Inc.

Start Trading GILD for Free

US$130.69

Price Arrow0.19 (0.146%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownEngulfing BullishHALO 200HALO 500HALO AllNear Support+2
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Gilead Sciences, Inc. Overview

GILD Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Weak

About GILD

icon
icon

Telephone

1.650.574.3000

icon

Address

333 Lakeside Drive, Foster City, CA 94404

Description

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

GILD Price Chart

Key Stats

Market Cap

US$162.02B

PE

18.10

EV/EBITDA

11.6

Dividends Overview

DIV Yield

2.6%

Franking

N/A

Ex Dividend Date (est.)

15-Jun-26

Market Data

52 weeks range

Low 104.46 - 157.29

Trade Value (12mth)

US$215,929,793.00

1 week

0.71%

1 month

-2.09%

YTD

7.32%

1 year

21.15%

All time high

157.29

Key Fundamentals

EPS 3 yr Growth

87.00%

EBITDA Margin

49.50%

Operating Cashflow

$10,019m

Free Cash Flow Return

22.20%

ROIC

18.90%

Interest Coverage

14.20

Quick Ratio

1.40

Other Data

Shares Outstanding (Fully Diluted)

1,254m

HALO Sector

Healthcare

Next Company Report Date

04-Feb-27

Next Ex Dividend Date

15-Jun-26

Next Dividend Pay Date

29-Jun-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

GILD Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
19 May 26
19 May 26
14 May 26

GILD Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock4.540.386.84locklocklock
EPS (Fully Diluted)
 $locklocklocklock4.50.386.78locklocklock
Growth
 %locklocklocklock24.1-91.51,677.3locklocklock
PE
 Xlocklocklocklock18241.518.1locklocklock
EV/EBITDA
 Xlocklocklocklock9.59.811.6locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

15-Jun-26

DIV Yield

2.6%

Franking Level

N/A

DPSg

2.6%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of Gilead Sciences, Inc. (GILD:NAS)?
Halo FAQ
The current share price of Gilead Sciences, Inc. (GILD:NAS) is USD$130.69.
What is the 52-week high share price for Gilead Sciences, Inc. (GILD:NAS)?
Halo FAQ
The 52-week high share price for Gilead Sciences, Inc. (GILD:NAS) is USD$157.29.
What is the 52-week low share price for Gilead Sciences, Inc. (GILD:NAS)?
Halo FAQ
The 52-week low share price for Gilead Sciences, Inc. (GILD:NAS) is USD$104.46.
What is the dividend yield for Gilead Sciences, Inc. (GILD:NAS)?
Halo FAQ
The current TTM dividend payout for Gilead Sciences, Inc. (GILD:NAS) is 2.60.
What was Gilead Sciences, Inc. (GILD:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Gilead Sciences, Inc. (GILD:NAS) is USD$0.82.
What is the franking level for Gilead Sciences, Inc. (GILD:NAS)?
Halo FAQ
Gilead Sciences, Inc. (GILD:NAS) has a franking level of 0.00%.
In which sector is Gilead Sciences, Inc. (GILD:NAS) classified?
Halo FAQ
Gilead Sciences, Inc. (GILD:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Gilead Sciences, Inc. (GILD:NAS)?
Halo FAQ
The current P/E ratio for Gilead Sciences, Inc. (GILD:NAS) is 18.10.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial